05/22/2025 12:00
Solidus Labs Unveils Agentic-Based Compliance: A New Model for Trade Surveillance Operations

Solidus Labs, the category-definer in trade surveillance and risk monitoring for digital and traditional asset classes, today announced the launch of Agentic-Based Compliance, a groundbreaking model for surveillance operations that leverages a network of AI agents to deliver exponential efficiency, precision, and intelligence across the entire trade surveillance and transaction monitoring investigation lifecycle. Legacy compliance solutions have failed to keep up with the rapid modernization a...

05/22/2025 12:00
Netomnia and Adtran deploy UK’s first commercial 50G PON service

Adtran and Netomnia today announced a major milestone in the evolution of the UK’s broadband market with the first-ever commercial deployment of a 50G PON service. Netomnia is using Adtran’s SDX 6400 Series to upgrade an existing residential customer with an ultra-high-speed service. The deployment is the first of its kind in the UK and will provide real-world insight into how providers can leverage next-generation PON technology to meet growing demand for ultra-high-speed connectivity. The fle...

05/22/2025 12:00
Rubedo Life Sciences Announces First Patient Dosed with Lead Drug Candidate RLS-1496, the First GPX4 Modulator Targeting Pathologic Senescent Cells To Enter Phase 1 Clinical Trial

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that the first patient has been dosed with lead drug candidate RLS-1496 in the company’s single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial. The study marks the first time a GPX4 (glutathione peroxidase) modulator has entered Phase 1 clinical trial and is designed to...